MEGHAN FERER: Open Payments
NPI 1730704776 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 12 payments from 9 companies in 2025. Trend: 2023 $917 · 2024 $888 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| TAIHO ONCOLOGY, INC. | 3 | $62 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| Genentech USA, Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $14 |
Products named: LIBTAYO, LONSURF, JEMPERLI, LYNPARZA, KEYTRUDA, TAVALISSE, JAKAFI, OJJAARA.
Industry payments across NC — which companies pay providers there.
